Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Markets

How should investors evaluate Advent Technologies Holdings Inc. (NASDAQ:ADN)?

January 25, 2023
in Markets

Stocks of Advent Technologies Holdings Inc. (NASDAQ:ADN) traded higher last session on Wall Street, up 0.52% to $1.94.

According to the data, Advent Technologies Holdings Inc. (NASDAQ:ADN) has 2 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $14.70 and a low of $4.00, we find $9.35. Given the previous closing price of $1.93, this indicates a potential upside of 384.46 percent. ADN stock price is now 2.53% away from the 50-day moving average and -16.34% away from the 200-day moving average. The market capitalization of the company currently stands at $98.16M.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

A total of 0 analysts have issued a hold rating and 2 have given it a buy rating. Brokers who have rated the stock have averaged $9.35 as their price target over the next twelve months.

With the price target maintained at $20, Goldman recently Downgraded its rating from Buy to Neutral for Advent Technologies Holdings Inc. (NASDAQ: ADN). On March 19, 2021, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $18.

Insiders disposed of 191,184 shares of company stock worth roughly $0.37 million over the past 1 year. A total of 13.80% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in ADN stock. A new stake in Advent Technologies Holdings Inc. shares was purchased by FIRST TRUST ADVISORS LP during the first quarter worth $648,000. VAN ECK ASSOCIATES CORP invested $267,000 in shares of ADN during the first quarter. In the first quarter, VIRTU FINANCIAL LLC acquired a new stake in Advent Technologies Holdings Inc. valued at approximately $82,000. MAN GROUP PLC acquired a new stake in ADN for approximately $65,000. HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND purchased a new stake in ADN valued at around $61,000 in the second quarter. In total, there are 81 active investors with 24.70% ownership of the company’s stock.

Tuesday’s opening bell rang with an opening price of $1.9300 for Advent Technologies Holdings Inc. (NASDAQ: ADN). During the past 12 months, Advent Technologies Holdings Inc. has had a low of $1.13 and a high of $4.81. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 4.40, and a quick ratio of 3.60. The fifty day moving average price for ADN is $1.8922 and a two-hundred day moving average price translates $2.3189 for the stock.

The latest earnings results from Advent Technologies Holdings Inc. (NASDAQ: ADN) was released for Jun, 2022. According to the Utilities – Renewable Company, earnings per share came in at -$0.22, beating analysts’ expectations of -$0.24 by 0.02. This compares to -$0.23 EPS in the same period last year. The company reported revenue of $2.4 million for the quarter, compared to $1.67 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 43.31 percent.

Advent Technologies Holdings Inc.(ADN) Company Profile

Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets. It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems. The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, HT-PEM based membrane electrode assemblies, membranes, and electrodes. It serves stationary and portable power, automotive, aviation, energy storage, and sensor markets. The company is headquartered in Boston, Massachusetts.

Tags: ADNADN stockAdvent Technologies Holdings Inc.NASDAQ:ADN

Related Posts

A breakdown of the latest mutual funds holding Rigel Pharmaceuticals Inc. (RIGL)

January 31, 2023

Investor Insight: Annaly Capital Management Inc. (NLY) Goes Ballistic – Investor Confidence on the Rise

January 31, 2023

Can Oracle Corporation (ORCL) stock recover despite sales dropping?

January 31, 2023

When is the right time to cash out of XP Inc. [XP] stock?

January 31, 2023

Is Citizens Financial Group Inc. [CFG] a good investment? Don’t be fooled by its recent momentum

January 31, 2023

Does British American Tobacco p.l.c. (NYSE:BTI) presents a BIG investment opportunity?

January 31, 2023
Next Post

Opera Limited (NASDAQ:OPRA): A Fundamentally Weighted Stock for Long-Term Investors

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Shell plc (NYSE:SHEL): A Fundamentally Weighted Stock for Long-Term Investors

2 months ago

There’s Still Time to Buy Latham Group Inc. (NASDAQ:SWIM) Stock

1 week ago

Do you still think Super Micro Computer Inc. (NASDAQ:SMCI) is worth a look?

4 months ago

Before Investing In Origin Bancorp Inc. (NASDAQ:OBNK), Here Are Some Things To Consider

4 days ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Does The Kraft Heinz Company (NASDAQ:KHC) warrant a purchase right now? What to Consider Before Making a Decision
  • A breakdown of the latest mutual funds holding Rigel Pharmaceuticals Inc. (RIGL)

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch